다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
NLS Pharmaceutics Ltd (NLSP)
NLS Pharmaceutics Ltd (NLSP) 뉴스

NLSP

NLS Pharmaceutics (NLSP)

NLS Pharmaceutics Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NLSP

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/12	05:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2024/02/24	06:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2024/01/13	07:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/30	06:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/23	06:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/07	06:44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/05	06:45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/05	06:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/12/01	21:35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/11/17	06:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/10/26	05:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/10/25	22:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/09/14	05:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/08/31	06:25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/07/21	05:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/07/04	02:22	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/06/14	21:38	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/06/09	21:30	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/05/08	21:31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/05/06	05:37	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/05/02	05:31	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/02/24	21:56	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/02/14	20:10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/02/02	06:02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/26	06:02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/24	06:31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/23	22:31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/23	20:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/14	06:03	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:NLSP	NLS Pharmaceutics Ltd
2023/01/12	22:31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NLSP	NLS Pharmaceutics Ltd

검색 관련기사 보기:NASDAQ:NLSP

1 2 3 4 다음 >>

Activision Blizzard

Vontobel Financial Produ...

BNP Paribas Issuance

Small Love Potion

National Lampoon

Strategic Income Select ...

ETC 6 Meridian Low Beta ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관